查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
全球活细胞成像市场-2022-2029
市场调查报告书
商品编码
1129280

全球活细胞成像市场-2022-2029

Global Live Cell Imaging Market - 2022-2029
出版日期: | 出版商: DataM Intelligence | 英文 180 Pages | 商品交期: 约2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

市场动态

利用活细胞成像新技术研究细胞生物学有望推动市场增长。

香港科技大学 (HKUST) 的研究人员开发出新一代显微镜，可捕捉 3D 活细胞电影并产生显着更高质量的图像，显着提高细胞生物学研究的精度和范围。改进为另一方面，由香港科技大学杜胜旺教授和 Michael Loy 教授领导的团队开发的 LiTone Line Bessel Sheet (LBS) 显微镜的光毒性比目前的共聚焦显微镜低 1000 倍，使细胞生长时间更长.时间可以观察。此外，它是一项基于广泛科学和工程的强大技术，但为用户简化了，因此即使是不太专业的生物学家也可以使用它。随着时间的推移，科学家们或许能够解开某些疾病如何在细胞水平上形成和发展的奥秘。因此，从上述陈述来看，预计将在预测期内推动市场。

限制

先进的活细胞成像技术和设备价格昂贵，缺乏熟练的专业人员，政府对设备和软件类型的严格批准是在预测期内阻碍市场的一些因素。考虑。

行业分析

活细胞成像市场基于供应链分析、报销方案和定价分析等各种行业因素对市场进行了深入分析。

COVID-19 影响分析

COVID-19 大流行对医疗保健系统和市场产生了适度影响。 COVID-19 研究人员正在使用远程活细胞成像技术来监测和研究病毒感染的细胞，而无需进入实验室。这可以节省时间并降低与 COVID-19 研究相关的风险。目前用于检查 SARS-CoV-2 细胞进入的基于细胞的检测使用真正的病毒或带有尖峰的假型病毒，这很耗时，需要生物安全设施和多步实验技术。这极大地阻碍了相关研究，尤其是高通量筛选实验。一些研究人员已经使用活细胞成像进行可视化，我们开发了一种可量化的荧光 SARS-CoV-2 进入探针。世界各地的研究人员正在研究产生 COVID-19 的病毒 SARS-CoV-2。在病毒研究期间，研究人员可以利用活细胞成像方法（例如先进的显微镜设备）来分析细胞活动。基于病毒学的研究需要处理大量数据才能进行疫苗接种。

另一方面，大流行会破坏供应炼和流程。许多公司转移到其他地区以确保产品可用性并保护其供应链。因此，从上面这句话来看，市场受到了影响，预计随着经济活动的恢復，市场将迅速获得牵引力。

全球活细胞成像市场报告提供大约 45 多个市场数据表、40 多个图表和 180 页内容。

内容

第一章研究方法与范围

  • 调查方法
  • 调查目的和范围

第 2 章市场定义和概述

第 3 章执行摘要

第 4 章市场动态

  • 市场影响因素
    • 驱动程序
      • 为细胞生物学研究捕获活细胞图像的新技术的开发预计将推动市场增长。
    • 限制因素
      • 缺乏熟练的专业人员以及政府对设备类型的严格批准预计会阻碍市场增长。
    • 市场机会
    • 影响分析

第五章行业分析

  • 供应链分析
  • 定价分析
  • 未满足的需求分析
  • 管道分析

第 6 章 COVID-19 分析

  • COVID-19 的市场分析
    • COVID-19 之前的市场情景
    • COVID-19 的当前市场情景
    • COVID-19 后或未来情景
  • COVID-19 期间的价格动态
  • 供需范围
  • 大流行期间与市场相关的政府举措
  • 製造商的战略举措
  • 总结

第 7 章按产品类型

  • 设备
    • 独立系统
    • 显微镜
    • 细胞分析仪
    • 图像捕捉设备
    • 其他
  • 消耗品
    • 试剂和试剂盒
    • 其他
  • 软件
  • 其他

第 8 章技术

  • 光漂白后的荧光恢復方法
  • 荧光共振能量转移法
  • 高内容分析
  • 荧光原位杂交
  • 其他

第 9 章。按应用程序

  • 药物发现
  • 细胞生物学
  • 发育生物学
  • 干细胞
  • 其他

第 10 章，最终用户

  • 製药公司、生物技术公司
  • 诊断实验室
  • 医院
  • 学术和研究机构
  • 其他

第 11 章按地区划分

  • 北美
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 法国
    • 意大利
    • 西班牙
    • 其他欧洲
  • 南美洲
    • 巴西
    • 阿根廷
    • 其他南美洲
  • 亚太地区
    • 中国
    • 印度
    • 日本
    • 澳大利亚
    • 其他亚太地区
  • 中东和非洲

第 12 章竞争格局

  • 主要发展和战略
  • 公司份额分析
  • 产品基准
  • 值得关注的重点公司列表

第 13 章公司简介

  • 珀金埃尔默公司
    • 公司简介
    • 产品组合和描述
    • 主要亮点
    • 财务摘要
  • Live Cell Instruments
  • Zeiss Group
  • Axion BioSystems, Inc
  • Becton, Dickinson and Company
  • CYTENA
  • Thermo Fisher Scientific
  • Bio-Rad Laboratories, Inc.
  • Agilent Technologies
  • Cytiva

第 14 章全球活细胞成像市场-DataM

简介目录
Product Code: DMBT5828

Market Overview

Live Cell Imaging Market size was valued US$ YY million in 2021 and is estimated to reach US$ YY million by 2029, growing at a CAGR of 8.8 % during the forecast period (2022-2029).

Live-cell imaging has revolutionized how scientists study cells, proteins, various processes and complicated molecular interactions. Using live-cell imaging techniques, researchers may view cell shapes and functions in real-time and over time. Instead of simply presenting an image of a cell's current state, live-cell imaging enables the visualization and characterization of dynamic cellular events and processes in real-time. Exploring dynamic processes, viewing the localization and mobility of particular molecules, and analyzing structural aspects of a cell are some of the most important uses of live cell imaging. Furthermore, live-cell imaging techniques enable scientists to monitor the physiological integrity of cells and other cellular and molecular processes such as exocytosis, signal transduction, enzyme activity, and protein trafficking.

Market Dynamics

The development of new technology to capture live cell images to study cell biology is expected to drive market growth.

Researchers at The Hong Kong University of Science and Technology (HKUST) have developed a new generation of microscopes that captures 3D live-cell movies and produces considerably higher quality images, greatly improving the accuracy and scope of cell biology research. The LiTone Line Bessel Sheet (LBS) microscope developed by a team led by Prof Du Shengwang and Prof Michael Loy from HKUST, on the other hand, is 1,000 times less photo-toxic than the present confocal model, allowing the cell to be observed for much longer. Moreover, it is a powerful technology based on extensive science and engineering, but we simplify it for users so that biologists with little expertise may use it. That could eventually help scientists unlock the mystery of how certain diseases were formed and developed at a cellular level. Thus, from the above statements, the market is expected to drive in the forecast period.

Restraint:

Advanced live-cell imaging technology and equipment are expensive, lack of skilled professionals and stringent government approvals for types of equipment and software are some factors the market is expected to get hampered in the forecast period.

Industry Analysis

The live cell imaging market provides in-depth analysis of the market based on various industry factors such as supply chain analysis, reimbursement scenario, pricing analysis etc.

COVID-19 Impact Analysis

The COVID-19 pandemic has moderately impacted healthcare systems and the market. COVID-19 researchers employ remote live-cell imaging to monitor and investigate virus-infected cells without entering the lab. This saves time and reduces the risks involved with the COVID-19 study. Current cell-based assays for examining SARS-CoV-2 cell entrance involve either an actual virus or spike-bearing pseudotyping viruses, which is time-consuming and necessitates biosafety facilities and multistep experimental techniques. This has significantly hampered relevant investigations, particularly high-throughput screening experiments. Several researchers have developed a fluorescent SARS-CoV-2 entry probe that can be visualized and quantified using live-cell imaging to implement an ideal system for high-throughput screening SARS-CoV-2 entry inhibitors in virus-free environments supporting antibody and vaccine development. SARS-CoV-2, the virus that produces COVID-19, is being studied by several worldwide researchers. Researchers can utilize live-cell imaging methods, such as advanced microscopy equipment, during the viral study to analyze cellular activities. Virology-based research necessitates the processing of vast amounts of data to generate vaccinations.

In contrast, the pandemic interrupts the supply chain and process. Many companies will vary to other geographic regions to ensure that products remain available and protect their supply chain. Thus, from the above statements, the market got affected, and it is expected to gain traction quickly with the resumption of economic activities.

Segment Analysis

Equipment segment is expected to hold the largest market share in live cell imaging market

The equipment segment is expected to dominate in 2021. The segment is further sub-segmented into standalone systems, microscopes, cell analyzers, and image capturing devices. In this, Equipment or devices that can function independently of other hardware and are not integrated into another device are called standalone systems. The extensive use of these systems in live-cell imaging and the rising emphasis on research and technological development are the primary reasons driving the segment's growth. Moreover, according to a February 2022 update, TGen and Deepcell partnered to classify and isolate sick cells using artificial intelligence-based technology. Deepcell's AI-powered technology transforms cell morphology into a quantitative and high throughput marker for use in research and a novel independent way to supplement existing molecular procedures. Thus, from the above statements, the market segment is expected to hold the largest market share in the forecast period.

Geographical Analysis

North America region holds the largest market share in the global live cell imaging market

In 2021, North America accounted for the highest revenue share. The rising geriatric population, significant commitment and funding available for live-cell imaging research, high adoption of innovative treatments, the presence of large pharmaceutical corporations and prominent research institutes, as well as their active involvement in the development and commercialization of novel, enhanced live-cell imaging systems in the region are some of the factors the market is expected to boost in the forecast period. For instance, PHC Corporation of North America announced cooperation with SCREEN Holdings Co., Ltd. on September 21, 2021, to market and distributed the SCREEN Cell3iMager family of live-cell imaging equipment in North America. Moreover, biopharmaceutical companies invested more than a trillion dollars in research and development over the last decade, including a record-breaking year in 2020, when PhRMA member companies invested approximately USD 91 billion in research and development. Thus, from the above statements, the North American region is expected to hold the largest market share in the forecast period.

Competitive Landscape

Major key players in the live cell imaging market are PerkinElmer Inc, Live Cell Instruments, Zeiss Group, Axion BioSystems, Inc, Becton, Dickinson and Company, CYTENA, Thermo Fisher Scientific, Bio-Rad Laboratories, Inc., Agilent Technologies , Cytiva.

PerkinElmer Inc.:

Overview:

PerkinElmer is a leading, global provider of end-to-end solutions that help scientists, researchers, and clinicians better diagnose disease, discover new and more personalized drugs, monitor the safety and quality of our food, and drive environmental and applied analysis excellence. The company has a dedicated team of more than 16,000 and collaborates closely with commercial, government, academic, and healthcare customers to deliver reagents, assays, instruments, automation, informatics, and strategic services that accelerate workflows, deliver actionable insights, and support improved decision making. The company serves customers in 190 countries and is a component of the S&P 500 index.

Product Portfolio:

MuviCyte Live-Cell Imaging Kit: The MuviCyte live-cell imaging system works inside your cell-culture incubator, allowing you to keep your cells in ideal conditions while performing various experiments in different culture containers. The MuviCyte live-cell imaging package includes a live-cell imaging apparatus as well as 4x, 10x, and 20x objective lenses, a PC, and a monitor.

The global live cell imaging market report would provide an access to an approx. 45+market data table, 40+figures and 180pages.

Table of Contents

1. Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Market Definition and Overview

3. Executive Summary

4. Market Dynamics

  • 4.1. Market Impacting Factors
    • 4.1.1. Drivers
      • 4.1.1.1. The development of new technology to capture live cell images to study cell biology is expected to drive market growth.
    • 4.1.2. Restraints:
      • 4.1.2.1. Lack of skilled professionals and stringent government approvals for types of equipment are expected to hamper the market growth.
    • 4.1.3. Opportunity
    • 4.1.4. Impact Analysis

5. Industry Analysis

  • 5.1. Supply Chain Analysis
  • 5.2. Pricing Analysis
  • 5.3. Unmet Needs
  • 5.4. Pipeline Analysis

6. COVID-19 Analysis

  • 6.1. Analysis of Covid-19 on the Market
    • 6.1.1. Before COVID-19 Market Scenario
    • 6.1.2. Present COVID-19 Market Scenario
    • 6.1.3. After COVID-19 or Future Scenario
  • 6.2. Pricing Dynamics Amid Covid-19
  • 6.3. Demand-Supply Spectrum
  • 6.4. Government Initiatives Related to the Market During Pandemic
  • 6.5. Manufacturers Strategic Initiatives
  • 6.6. Conclusion

7. By Product Type

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
    • 7.1.2. Market Attractiveness Index, By Product Type Segment
  • 7.2. Equipment
    • 7.2.1. Standalone Systems
    • 7.2.2. Microscopes
    • 7.2.3. Cell Analyzers
    • 7.2.4. Image Capturing Devices
    • 7.2.5. Others
    • 7.2.6. Introduction
    • 7.2.7. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
  • 7.3. Consumables
    • 7.3.1. Reagents and Kits
    • 7.3.2. Others
  • 7.4. Software
  • 7.5. Others

8. By Technology

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Technology
    • 8.1.2. Market Attractiveness Index, By Technology Segment
  • 8.2. Fluorescence Recovery After Photobleaching*
    • 8.2.1. Introduction
    • 8.2.2. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
  • 8.3. Fluorescence Resonance Energy Transfer
  • 8.4. High-content Analysis
  • 8.5. Fluorescence In Situ Hybridization
  • 8.6. Others

9. By Application

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 9.1.2. Market Attractiveness Index, By Application Segment
  • 9.2. Drug Discovery*
    • 9.2.1. Introduction
    • 9.2.2. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
  • 9.3. Cell Biology
  • 9.4. Developmental Biology
  • 9.5. Stem Cells
  • 9.6. Others

10. By End user

  • 10.1. Introduction
    • 10.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End user
    • 10.1.2. Market Attractiveness Index, By End user Segment
  • 10.2. Pharmaceutical and Biotechnology Companies*
    • 10.2.1. Introduction
    • 10.2.2. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
  • 10.3. Diagnostic Laboratories
  • 10.4. Hospitals
  • 10.5. Academic and Research Institutes
  • 10.6. Others

11. By Region

  • 11.1. Introduction
    • 11.1.1. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029, By Region
    • 11.1.2. Market Attractiveness Index, By Region
  • 11.2. North America
    • 11.2.1. Introduction
    • 11.2.2. Key Region-Specific Dynamics
    • 11.2.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
    • 11.2.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Technology
    • 11.2.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 11.2.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End user
    • 11.2.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 11.2.7.1. U.S.
      • 11.2.7.2. Canada
      • 11.2.7.3. Mexico
  • 11.3. Europe
    • 11.3.1. Introduction
    • 11.3.2. Key Region-Specific Dynamics
    • 11.3.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
    • 11.3.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Technology
    • 11.3.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 11.3.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End user
    • 11.3.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 11.3.7.1. Germany
      • 11.3.7.2. U.K.
      • 11.3.7.3. France
      • 11.3.7.4. Italy
      • 11.3.7.5. Spain
      • 11.3.7.6. Rest of Europe
  • 11.4. South America
    • 11.4.1. Introduction
    • 11.4.2. Key Region-Specific Dynamics
    • 11.4.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
    • 11.4.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Technology
    • 11.4.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 11.4.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End user
    • 11.4.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 11.4.7.1. Brazil
      • 11.4.7.2. Argentina
      • 11.4.7.3. Rest of South America
  • 11.5. Asia Pacific
    • 11.5.1. Introduction
    • 11.5.2. Key Region-Specific Dynamics
    • 11.5.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
    • 11.5.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Technology
    • 11.5.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 11.5.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End user
    • 11.5.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 11.5.7.1. China
      • 11.5.7.2. India
      • 11.5.7.3. Japan
      • 11.5.7.4. Australia
      • 11.5.7.5. Rest of Asia Pacific
  • 11.6. Middle East and Africa
    • 11.6.1. Introduction
    • 11.6.2. Key Region-Specific Dynamics
    • 11.6.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
    • 11.6.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Technology
    • 11.6.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 11.6.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End user

12. Competitive Landscape

  • 12.1. Key Developments and Strategies
  • 12.2. Company Share Analysis
  • 12.3. Product Benchmarking
  • 12.4. List of Key Companies to Watch

13. Company Profiles

  • 13.1. PerkinElmer Inc.*
    • 13.1.1. Company Overview
    • 13.1.2. Product Portfolio and Description
    • 13.1.3. Key Highlights
    • 13.1.4. Financial Overview
  • 13.2. Live Cell Instruments
  • 13.3. Zeiss Group
  • 13.4. Axion BioSystems, Inc
  • 13.5. Becton, Dickinson and Company
  • 13.6. CYTENA
  • 13.7. Thermo Fisher Scientific
  • 13.8. Bio-Rad Laboratories, Inc.
  • 13.9. Agilent Technologies
  • 13.10. Cytiva

LIST NOT EXHAUSTIVE

14. Global Live Cell Imaging Market - DataM

  • 14.1. Appendix
  • 14.2. About Us and Applications
  • 14.3. Contact Us